XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. (SEC CIK 0001697805) is a biopharmaceutical holding company that emerged from a SPAC business combination and operates in the healthcare and oncology sector. The company filed an 8-K with the Securities and Exchange Commission on April 4, 2019, accession number 0001213900-19-005742, reporting a material corporate event consistent with post-merger reporting obligations. The entity's formation reflects the broader trend of life-sciences companies accessing public markets through blank-check vehicle structures during the late 2010s SPAC cycle. Sign up for SpacDesk to access the full filing history, deal timeline, and sponsor data for Xynomic Pharmaceuticals Holdings and hundreds of other SPAC transactions.